← Back to Search

Stent-Graft

Talent Stent-Graft for Abdominal Aortic Aneurysm

N/A
Waitlist Available
Led By Manish Mehta, MD, MPH
Research Sponsored by Center for Vascular Awareness, Albany, New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights

Study Summary

The purpose of this study is to compare acute technical outcomes of the Talent AAA Stent Graft system versus Cook Zenith Endograft at two high volume institutions, Albany Medical Center and St. Peter's Hospital in Albany, NY. The investigators are comparing the two devices as part of the evolution of endovascular repair (EVAR) for AAAs. The Zenith AAA Endovascular Graft received FDA approval on May 23, 2003, the Talent Abdominal Stent Graft System on April 15, 2008.

Eligible Conditions
  • Abdominal Aortic Aneurysm

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acute technical success, successful exclusion of the aneurysm

Trial Design

2Treatment groups
Experimental Treatment
Group I: Talent Stent-GraftExperimental Treatment2 Interventions
Group II: Cook Zenith Stent-GraftExperimental Treatment2 Interventions

Find a Location

Who is running the clinical trial?

Center for Vascular Awareness, Albany, New YorkLead Sponsor
1 Previous Clinical Trials
2 Total Patients Enrolled
Manish Mehta, MD, MPHPrincipal InvestigatorThe Vascular Group, PLLC
3 Previous Clinical Trials
306 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~13 spots leftby May 2025